Making Sense of Glucose Monitoring. My Journey with Glucose Monitoring Over the Last 37 Years 8/7/2017

Similar documents
Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)

Applications of Technologies to Your Patient. Irl B. Hirsch, MD Professor of Medicine University of Washington School of Medicine Seattle, Washington

Advances in Diabetes Care Technologies

Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD

REPORT INTERPRETATION

Today s Goals 10/6/2017. New Frontiers in Diabetes Technology. Disclosures

Advances in Diabetes Care Technologies

Continuous Glucose Monitoring (CGM)

Updates in Diabetes Technology

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Incorporating CGM Into Clinical Decision

Clinical Value and Evidence of Continuous Glucose Monitoring

Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Continuous Glucose Monitors for Diabetes Management

Technology in Diabetes Management Irl B. Hirsch, MD University of Washington

Information Overload! CGM, Navigating for Success. Presented by: Kathi Milton RD, CDE and Amy Foreman RN, CDE

The Realities of Technology in Type 1 Diabetes

1. Continuous Glucose Monitoring

Pump and Sensor Data Interpretation. Irl B. Hirsch, MD University of Washington School of Medicine

Diabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018

Making the Most of Continuous Glucose Monitoring

Real-Time Continuous Glucose Monitoring: From Application to Evaluation

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Using and Interpreting Diabetes Data. Irl B. Hirsch, MD University of Washington

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights

Comparing the use of SMBG vs. CGM data to Optimize Glucose Control in T2DM

Report Reference Guide

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

ORIGINAL ARTICLE. Use of Freestyle Libre Pro TM Flash Glucose Monitoring System in Different Clinical Situations at a Diabetes Centre

Insulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming

Advances in Diabetes Care Technologies

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights

CONTINUOUS OR INTERMITTENT GLUCOSE MONITORING IN INTERSTITIAL FLUID

Paradigm/Guardian CGM Screens. CareLink Online Reports. Make Your Own Jackson Pollack. CGM by Jackson Pollack. How To Read CGM Screens/Reports

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

Diabetes Technology for the Endocrinologist, Irl B. Hirsch, MD University of Washington

Continuous Glucose Monitoring

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد

Individualizing Therapy int2dm With Insulin

10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:

An Evaluation of the Barriers to Patient use of Glucometer Control Solutions: A Survey of Patients, Pharmacists, and Providers

Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?

Corporate Medical Policy

PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)

CGM and Closing The Loop

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections

Assessing the value of the Ambulatory Glucose Profile in clinical practice

Continuous Glucose Monitoring: Changing Diabetes Behavior in Real Time and Retrospectively

The next five years in diabetes technology: closed-loop systems

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD

Endocrine Update Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh

Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes. Elena Toschi, MD November 12, 2016

Technology in Diabetes Care: Emerging Level

The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy. Today s Presenter

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

1 Dexcom G4 Platinum User Guide May 2012

FAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication

Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD

NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

When Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida

OneTouch Reveal web app Report Reference Guide

Continuous Glucose Monitoring (CGM)

Report Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1

Dr Sander Zwart MD, FACP, ECNU Arizona-AACE 2016 Annual Meeting

First steps for success.

How I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary

Abbott FreeStyle Libre Pro System

Timely!Insulinization In!Type!2! Diabetes,!When!and!How

Continuous Glucose Monitoring Devices Pharmacy Policy

Diabetes Management: Current High Tech Innovations

Insulin Initiation and Intensification. Disclosure. Objectives

Starting and Helping People with Type 2 Diabetes on Insulin

Flash Glucose Monitoring & Implantable Sensors

Blood Glucose Monitoring Clinical Applications

31 days Wed Nov 15, Fri Dec 15, 2017 N/A. Hypoglycemia. Sensor usage (CGM) Mahlon's glucose data was in the target range about 77% of the day.

Abbott FreeStyle Libre Pro System

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico

Welcome to CareLink Pro

ADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM

Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives

Commissioning Policy Individual Funding Request

Glycemic Variability:

Diabetes Technology in Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA

Predicts and helps prevent lows with. zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY

The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT

Beyond Basal Insulin: Intensification of Therapy Jennifer D Souza, PharmD, CDE, BC-ADM

Update on Diabetes Technology

This certificate-level program is non-sponsored.

Pumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University

Interpreting the charts & graphs

4/2/2018 MOVING THROUGH PREGNANCY WITH TECHNOLOGY CLINICAL EXPERIENCE WITH PUMPS, CGMS AND THE HYBRID CLOSED LOOP CONFLICT OF INTEREST DISCLOSURE

Usefulness of Ambulatory Glucose Profile (AGP) in Diabetes Care

4/16/2018. Flexible Intensive Insulin Therapy (FIIT) in People with Type 2 Diabetes: A Viable Option. Disclosures. Outline. No financial disclosures

Transcription:

HSW1 Disclosure to Participants Making Sense of Glucose Monitoring Alison B. Evert, MS, RD, CDE UW Neighborhood Clinics UW Medicine Seattle, WA Conflict of Interest (COI) and Financial Relationship Disclosures: Clinical Advisory Board: Senseonics Program Goals Describe how you can evaluate glucose data from glucose meter and continuous glucose monitoring (CGM) reports My Journey with Glucose Monitoring Over the Last 37 Years Participants will be able to state pros and cons of use of personal or professional CGM Given a case scenario, participants will utilize patient data to evaluate glucose levels to make treatment recommendations What I m Not Going to Cover Greenwood DA, et al. J Diab Sci Technol. Published online June 2017 Limitations of Glucose Monitoring Methods Current Tools for Understanding Glucose Dynamics A1c SMBG CGM Gold Standard Worldwide: Provides 90 day average Healthcare provider uses in decision-making Important Tool for People with Diabetes (PWD): Helps with day to day decision making Assists healthcare provider adjustments Provides significant amount of glucose data Healthcare provider and PWD learning how to interpret and use this data: Source: BBC, US T1 Diabetes Exchange 2011, dq&a Q42011, ADC Category Revenue Estimates. 1

Slide 2 HSW1 Hope Warshaw, 3/31/2017

A1C What Does it Really Tell Us? Complexities of Glucose Fluctuations Relying on only one testing method to reveal information about variability is suboptimal Both the person with diabetes (PWD) and healthcare providers need comprehensive, accurate, and actionable information about glucose levels and variability to achieve management goals Nathan DM, et al. Diabetes Care. 2008;31:1473-1478. Self Monitoring Blood Glucose (SMBG) Did You Bring Your Meter to Your Appointment Today? Why would the RDN need my meter? Evidence-Based Recommendations Frequency blood glucose checks per day May depend on insurance coverage and/or financial resources Most patients using intensive insulin regimens (multiple-dose insulin or insulin pump therapy) should perform self-monitoring of blood glucose (SMBG) prior to meals and snacks, at bedtime, occasionally postprandially, prior to exercise, or when they suspect low blood glucose When prescribed as part of a broad educational program, SMBG may help to guide treatment decisions and/or self-management for patients taking less frequent insulin injectionsor noninsulin therapies Diabetes Care. 40(Suppl. 1):S1 S135, 2017 What s the Evidence Integrating Nutrition Therapy - SMBG & CGM? Glucose monitoring is a valuable tool for assessing food, activity, and medications when data used for decision-making Glucose monitoring can provide insights into the influence of macronutrients on prandial glucose response. 1 Lyons L, Powers M, Austin M: ADA Guide to Nutrition Therapy. In chapter 22: Integrating Nutrition Therapy, Blood Glucose Monitoring, and Continuous Glucose Monitoring. 3 rd Edition, 2017 2

SMBG Data Sharing - Handwritten Records Real-life challenges Typically no direction for organization of data No advice on times to check Lack of targets Inadequate time to detect patterns Hypo- and hyperglycemia often missed & overnight Practice Pearl: Journal of Self-Discovery YOU CAN: Provide guidance & direction Set expectation YOU will look at data every visit Food records + BG data: Document episodes of food and beverage intake Household measurements If applicable: insulin injections how much for food & how much for BG correction Harris MI. Diabetes Care. 24(6):979-982, 2001 SMBG Data Sharing - Electronic Data Reports: Look at overall and time-specific averages and trends not possible with handwritten log-book records or information from interviews BG Monitoring 101: Glucose average (mean): Overall Time period Standard Deviation: How much the glucose is above and below the average glucose level Drastic Variations = Glycemic Variability Bergenstal R et al. J Diab Sci Technol. 7:562-578, 2013 Suh S et al. Diab Metab. 39:273-282, 2015 Average Mean & Standard Deviation Blood Glucose Meter Download Standard Deviation = SD Twice the standard deviation should be less than the average blood glucose level (SD 2 < average) Example: Average: 164 mg/dl Average: 164 mg/dl SD: 50 SD: 119 Hirsch I. Endo Prac. 10:67-76, 2008 3

Person with T1D New patient to our practice 35 year old male, father of 4 young children A1c = 6.3% Lives in rural Washington state Job requires that he drive a lot during the day Wife trying to lose her baby weight Family eating healthier & recently started working out has lost 10 lbs Blood Glucose Download Settings on Insulin Pump Adherence Reports: Practice Pearl SMBG Set expectation that BG results will be evaluated at EVERY appointment BG Targets - 2017 American Diabetes Association Recommendations Glucose Goals Fasting or Pre-meal: 80-130 mg/dl Post-Prandial (peak 1-2 hours) after meal: <180 mg/dl Or adjust based on the needs of the individual PWD Continuous Glucose Monitoring (CGM): Food Choices In Living Color aka as job security for RDN & diabetes educator Diabetes Care. 40(Suppl. 1):S1 S135, 2017 4

Dexcom G4 Medtronic i-pro2 Freestyle Libre Pro Professional CGM in US Personal CGM in US Hybrid closed loop pump: Medtronic 670G CGM enabled pump: Medtronic 530G + Revel Animas Vibe+ Dexcom G4 Tandem t:slim+ Dexcom G4 Stand Alone: DexCom G5 + G4 Rationale for Use? Professional vs. Personal Professional Identification of glucose patterns hypo- or hyperglycemia Adjustment of medication New patient/client to your clinic to obtain baseline data Have no idea what is going on Personal Ability to see glucose trends Prevention of severe hypoglycemia and reduction of prolonged hyperglycemia Dexcom use as an adjunctive device to complement, not replace, information obtained from SMBG Medtronic hybrid closed loop technology CGM Reports Although each CGM company has different generated reports, the information is generally the same and includes: Statistics/Summaries Birds Eye View Daily View Statistics/Summary Reports Statistics/Summary Reports Provides valuable information Time in target range compared to time high or low Accuracy of the sensor data Quantitative analysis of glucose excursions 5

Birds Eye View Birds Eye View: DexCom Studio - Overlay Glucose trend reports Identify glycemic patterns (or lack of patterns) Identifies glycemic patterns by overlaying the sensor readings of each day into one graph Can assist in pattern and trend recognition. Examples of 2 different reporting types Birds Eye View: Medtronic - Overlay Birds Eye: t:connect CGM Hourly Report Birds Eye: DexCom Clarity Everyone knows what a EKG tracing report looks like Unfortunately until recently data output for different CGM devices was NOT standardized. 6

FreeStyle and related brand marks are trademarks of Abbott Diabetes Care Inc. in various jurisdictions. Other trademarks are the property of their respective owners. 8/7/2017 Ambulatory Glucose Profile (AGP) Graph Review 1,2 AGP Graph Review Median, middle of all the data points 90 th Percentile 75 th Percentile, Above the 90 th Percentile, 10% of data 10 th Percentile 10-90 th percentile- 80% of all data 25 th Percentile, Interquartile Range (IQR), 50% of all the data Below the 10 th Percentile, 10% of data 1 Clinician Reviews. 26(1):S1-S8, 2016; 2 Wright E, J Fam Prac. 64(12):S2-S5, 2015 AGP Graph Review: Time In Range Unknown Daily Glucose Fluctuations Glucose Fluctuations of Four T1D Patients A1c = 7.6 to 7.7% Source: Dunn TC, Hayter GA, Doniger KJ, Wolpert HA. Journal of Diabetes Science and Technology. Published online 17 Apr 2014. Matthaei, et al. British Journal Diabetes Vascular Disease.14(4):152-157, 2014 Birds Eye & Daily Views Tim T1D, Aspergers Syndrome, age 47, BMI: 28 80+ year old parents, safety of living independently? MDI: glargine 35 BID, lispro 20 units per meal A1c: 13% SMBG: Average: 183 mg/dl SD: 87 Frequency SMBG: < 1 x/day 7

Pete T2D x 28 yrs Recently dx CKD stage 3, neuropathic pain in his feet and hands BMI: 38 A1C 9.7% Wake-up call after learning of decline in renal function First appointment ever with RDN/CDE after Libre MDI: Basaglar 25 units BID Aspart 10-20 units per meal based on WAG method DexCom G-5 latest version Sharing Data with Educator 8

Practice Pearls: An Actionable Surprise For All Users Breakfast bump Refined/processed foods/smoothies Post-activity glucose response Observe glucose response to different types food Pizza effect prolonged postprandial hyperglycemia Nocturnal hypoglycemia Hypoglycemia unawareness Over-correction for hyperglycemia Practice Pearl: Timing of insulin dose lag-time Ask patients about insulin action: onset peak duration Difficult to be under 200 mg/dl peak after eating unless injecting/bolusing 15-20 minutes before start of meal However use of lag-time must be balanced with safety Viewing real-time glucose data can increase risk of STACKING Visual Reinforcement of Stacking Concept DeWitt DE, Hirsch IB. JAMA. 289:2254-2264, 2003 Scaramuzza AE, et al. Diabetes Technol Ther. 12:149-152, 2010 Cobry E, et al. Diabetes Technol Ther. 12:173-177, 2010 Luijf YM, et al. Diabetes Care. 33:2152-2155, 2010 Lag Times Based on Degree of Pre-prandial Hyperglycemia Practice Pearl: Timing of Prandial Insulin Pre-Meal Blood Glucose (mg/dl) Lag Time (minutes) 80-99 0 100-199 10-20 200-299 20-30 >300 30-40 Tridgell DM, Tridgell AH, Hirsch IB. Endocrinol Metab Clin North Am. Tridgell DM, Tridgell 2010;39:595-608. AH, Hirsch IB. Endocrinol Metab Clin North Am. 39, 2010:595-608. 9

Practice Pearls: Maximizing Education Sessions Encourage use of portals and BG software to upload data! Data analysis helps to makes adjustments with pump settings for activities of daily living : Physical activity Stress/Illness Restaurant meals Travel Menses Practice Pearl: Look for Cheat Sheets Most companies provide a cheat sheet with computer generated strategies recognized by patterns Practice Pearl: Organizational Support Endocrine Society Clinical Practice Guideline Diabetes Technology Co-sponsored by AADE Support for Role of CDE in CGM Journal Clinical Endocrinology and Metabolism. 2016;101(11):3922-3937 Support for Role of CDE in CGM Summary Research shows the glucose data need to be used for decision-making; otherwise, value in reducing A1c and complications is questionable. Alison Evert, MS, RD, CDE aevert@uwpn.org Lyons L, Powers M, Austin M: ADA Guide to Nutrition Therapy. In chapter 22: Integrating Nutrition Therapy, Blood Glucose Monitoring, and Continuous Glucose Monitoring. 3 rd Edition, 2017 10